LOCAL clinical trials will soon commence for two Covid-19 vaccines developed by a US-based company to target four variants of concern, including Delta.
The early-stage clinical trial, which has just received approval from the Health Sciences Authority, will evaluate the vaccines’ safety and immune response against the Alpha, Beta, Gamma and Delta variants, and as possible booster shots for vaccinated people.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
